Henriques, V. (2025). Analysis of the clinical value and applicability of tumour regression grading systems for pancreatic ductal adenocarcinoma with FOLFIRINOX as first-line neoadjuvant therapy.
Chicago-Zitierstil (17. Ausg.)Henriques, Vanessa. Analysis of the Clinical Value and Applicability of Tumour Regression Grading Systems for Pancreatic Ductal Adenocarcinoma with FOLFIRINOX as First-line Neoadjuvant Therapy. Heidelberg, 2025.
MLA-Zitierstil (9. Ausg.)Henriques, Vanessa. Analysis of the Clinical Value and Applicability of Tumour Regression Grading Systems for Pancreatic Ductal Adenocarcinoma with FOLFIRINOX as First-line Neoadjuvant Therapy. 2025.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.